PHARMACY FORMULARY UPDATES
Effective April 1, 2023; Albuterol HFA will be limited to ONE inhaler per 30 days without a prior authorization.
If your patient has asthma and needs more than 1 albuterol HFA inhaler per month, please consider changing to budesonide/formoterol, as it can be used as a rescue and a maintenance inhaler.
If your patient has COPD and needs more than 1 albuterol inhaler, please consider starting Incruse Ellipta. If your patient is already on Incruse Ellipta and symptoms aren’t managed, please consider submitting a prior authorization request for a combination inhaler.
See the list of the current formulary inhalers but as always, please refer to the website for the most up to date information in the future.
|